Notably, a consistent fraction of cases carries de-novo SMARCB1/INI1 constitutional mutations in the setting of the so called “rhabdoid tumor predisposition syndrome” [5,6]. The gene discussed is SMARCB1; the disease is familial rhabdoid tumor.